US aid payments fell by three quarters, and the Global Fund lets countries shop with World Bank loans

US foreign-aid payments that actually went out fell by three quarters between fiscal years 2025 and 2026, and health lost the most money. The Global Fund, facing a $5.32 billion gap, appointed a former head to lead it again and opened its pooled purchasing platform to countries that borrow from the World Bank. In an experiment with 50 professional analysts, people working with a coding agent took its side on analytic choices 86% of the time and seldom said the argument was the agent's. At a Korean university hospital, seven of nine paediatric emergency staff have resigned after a police raid, while the government drafts a list of 1,440 procedures that would limit doctors' criminal exposure. In Zurich, one inpatient in fifteen was delirious on a single day, a condition that often never reaches the chart, which makes delirium today's medicine concept.

Connecting the dots

Who pays, and who declines to pay. The aid figures are blunt: "Reported disbursements fell from $47.84 billion in FY2025 to $11.75 billion in FY2026." (ICTworks). The Global Fund's response is to let loans buy what grants used to: the new agreement "will enable countries to use World Bank financing to buy quality-assured health products through" its pooled platform (Global Fund). A US health economist describes the same lever from the buyer's side: when California's public employee plan "set a reference price for hip and knee replacements", "High priced hospitals cut their prices sharply." (STAT). Speculation: as grant money shrinks, what a large purchaser refuses to pay may shape what reaches clinics as much as the size of the grants.

Three ways judgement slips when a model is in the loop. Analysts working with an agent "went with their agent's lean 86% of the time" (Anthropic). Language models judging whether research ideas are new turned out to depend on wording: "accuracy dropped from 93.5% to 40.9% – below chance" with a simpler prompt (Ai2). And a genomics researcher found that "AI wrote the longest review I have seen in my career but it missed the weakest link in the manuscript." (Heng Li). Exit and voice, in hospitals, the same week. Today's book argues that the "customers who care most about the quality of the product" are "apparently likely to exit first", which "paralyzes voice by depriving it of its principal agents" (Sethi, quoting Hirschman). In Korea most of a paediatric emergency team resigned, and in Vaud citizens are collecting signatures to vote on a hospital's software. In Japan, close to eight in ten nursing staff are dissatisfied with their pay, which (translated from Japanese) "could lead to nursing staff leaving for other industries" (original: 「看護職員の他産業への流出につながりかねない」) (CBnews). Speculation: in a system short of staff, the people who leave first may be the ones whose complaints would have forced the repair.

Clinical trials

Culturally adapted psychoeducation delayed relapse in bipolar disorder in Pakistan

"CaPE prolonged time to recurrence of any mood episode versus TAU (adjusted hazard ratio 0.54, 95% CI 0.42-0.69; p < 0.001)" — EClinicalMedicine, via PubMed

An assessor-masked trial at seven urban centres, 303 adults in remission, 48 weeks, against usual care. It shows a teaching programme, adapted to local culture, doing the work of relapse prevention.

Screening pregnant women for sexually transmitted infections did not prevent preterm birth

"Neither STI screening strategy reduced the primary composite outcome or low birthweight alone." — Clinical Infectious Diseases, via PubMed

In South Africa, 2,247 pregnant women were randomised to one screening, two screenings or standard care, which treats infections from symptoms. The trial asked whether the extra test changes the birth, and it did not.

An amyloid antibody cleared amyloid and cognition did not follow

Sabirnetug, which targets amyloid-beta oligomers, "did not meet its primary endpoint" in early Alzheimer's disease, although amyloid on PET "showed statistically significant reductions for both dose levels at weeks 36 and 76"; the company will "cease development of the investigational monoclonal antibody" (Psychiatric Times).

Also this week

• Pacing: in 14 Chinese hospitals, for heart block with preserved pumping function, pacing the left bundle branch area "significantly reduced the primary end point vs RVP (2.4% vs 12.5%" (death, heart-failure events or upgrade over 24 months) (JAMA, via PubMed).
• Weight and diabetes: in a company topline, not yet peer reviewed, retatrutide against semaglutide "produced more than double the weight loss (19.5% and 20.9% versus 9.4%)", with discontinuation for adverse events at 7.9% against 2.7% (2 Minute Medicine).
• AI in therapy: a Hong Kong alcohol chatbot "did not show an incremental effect on alcohol consumption" over a standard brief intervention (PubMed); in Swedish internet therapy for social anxiety, AI feedback did not differ statistically from therapists' but "non-inferiority was not established" (PubMed).

Hospitals

Korea: a paediatric emergency centre empties after a police raid

(translated from Korean) "It is reported that 7 of the 9 medical staff at Ajou University Hospital's paediatric emergency centre have offered to resign" … the director: "I cannot guarantee how many specialists will stay to keep the centre running." — Korean Doctors' Weekly Original: "아주대병원 소아응급의료센터 의료진 9명 중 7명이 사의를 표명한 것으로 알려진 가운데" … "몇 명의 전문의가 남아 센터를 지킬 수 있을지 장담하지 못하겠다"

Police searched the centre while staff were treating a seizing infant; senior officers have since apologised. In parallel, specialist societies have drafted "a 1,440-item candidate list" of high-risk procedures for which an amended law would limit prosecution (translated from Korean; original: "1,440건의 후보 목록을 마련했다") (Korean Doctors' Weekly), if all five conditions are met, liability insurance among them. Why it matters: a centre can lose most of its doctors in one month, and the legal fix is still a list under review.

Germany: three hospitals in four ran a deficit last year

(translated from German) "In 2025, almost three quarters (73 percent) of hospitals were in the red." … "The number of insolvencies will probably rise sharply." — Deutsches Ärzteblatt, on a survey of about 600 hospital leaders Original: „2025 waren demnach fast drei Viertel (73 Prozent) der Kliniken in den roten Zahlen." … „Die Zahl der Insolvenzen wird wahrscheinlich stark steigen"

More than half are postponing investments to cope.

Italy: a new ceiling on devices

From 2027 (translated from Italian) "the national ceiling for medical-device purchases is set at 4.7% of health funding" (original: "il tetto nazionale per gli acquisti di dispositivi medici viene fissato al 4,7% del finanziamento sanitario"), alongside €2.365 billion more for the health fund (Quotidiano Sanità). The old ceiling had been breached in every region.

Switzerland: a referendum against Epic in Vaud's hospitals

A cross-party committee wants a public vote on the US record system planned for the Lausanne university hospital and eleven regional hospitals: (translated from French) "A vendor subject to the US CLOUD Act can be compelled to hand over our data" (original: « Un éditeur soumis au CLOUD Act américain peut être contraint de livrer nos données ») (Medinside). It needs 12,000 signatures by 5 December, and where patient data may be held becomes a question for voters.

Medicine concept of the day

Delirium: a two-minute test that someone has to remember to do

"Delirium is an acute, transient, usually reversible, fluctuating disturbance in attention, cognition, and consciousness level." — Merck Manual Professional

The core sign is inattention, tested at the bedside by "digit span (ability to repeat 7 digits forward and 5 backward), and naming the days of the week forward and backward." The quiet form is the one that slips through: "Very old people with delirium tend to become quiet and withdrawn—changes that may be mistaken for depression."

At the University Hospital Zurich, nurses screened every eligible inpatient on one day: "The point prevalence across all settings was 6.9% (27/390)", and "delirium is often unrecognised, undiagnosed and uncoded" (Schiess et al., J Clin Nurs). Spanish geriatricians call it (translated from Spanish) "among the most frequent in clinical practice and, at the same time, among the most underdiagnosed" (original: "entre las más frecuentes en la práctica clínica y, al mismo tiempo, entre las más infradiagnosticadas") (Redacción Médica).

The tool matters. Validation studies gave the Confusion Assessment Method (CAM) "an overall sensitivity of 94%" (Wei et al., 2008); head to head on an acute medical ward, "The 4AT had a sensitivity of 76%" and "The CAM had a sensitivity of 40%" (Shenkin et al., BMC Med 2019). The 4AT takes "~2 min" (the4at.com).

Treatment is mostly prevention: "primary prevention of delirium is probably the most effective treatment strategy" (Inouye et al., NEJM 1999); in intensive care, antipsychotics "did not significantly alter the duration of delirium" (Girard et al., NEJM 2018). And "30 to 50 % of hospitalized patients with delirium die within 1 year" (Merck Manual).

Why it matters: any model trained on coded diagnoses inherits the cases nobody screened for, and the hypoactive ones are the likeliest to be missing.

Health systems and policy

The Global Fund changes hands and changes how countries can pay

The Fund is "confronting an unprecedented $5.32 billion funding gap", and Mark Dybul, who led it from 2013 to 2017, returns as Executive Director in early 2027: "There is a very narrow window of opportunity – 12 to 18 months – to get it right this time" (Health Policy Watch). In a follow-up interview he puts the attention on countries: "The focus needs to be in the country and how we all work together to support them." (Health Policy Watch). The World Bank route is optional: "Use of the platform will be a choice made by each country" (Global Fund).

Seven candidates for WHO Director-General

The Executive Board shortlists five in early 2027; "At its 80th session in May 2027, the World Health Assembly will appoint the new Director-General." and "The new Director-General will take office on 16 August 2027." (WHO). The winner will run a WHO without US funding.

Ebola in central Africa is now the second-largest outbreak on record

"As of October 28, 10,193 cases and 4,960 deaths have been recorded" … "the outbreak in DRC is likely to persist and inevitably continue to cause secondary epidemics" — Think Global Health

Effectiveness data for a Bundibugyo vaccine "is not expected until at least March 2027", and MSF asks the manufacturer to "allocate all Ervebo doses produced in the coming months for the global stockpile" (MSF Access).

WHO writes TB drug targets around the number of visits

"The profile for TB preventive treatment aims at a full course given as a single injection at one encounter." "The profile for TB disease aims at a regimen of no more than four months, given in three or fewer dosing encounters." — WHO

For drug developers, the number of times a patient must come back is now part of the specification.

Big in machine learning

Google's new frontier model goes first to cyber defenders

Google says "Carbon ranks #1 on the recently updated v5.0 of Artificial Analysis Intelligence Index at 59", and "We're taking a deliberate approach to rollout": "Starting this week, we will make Carbon available to a subset of cyber defenders" (Google). The same week Anthropic reported that its unreleased model's Chrome findings led to "62 CVEs" assigned and patched (Anthropic), and Epoch AI showed an open model "reverse-engineering vulnerabilities from security fixes that Mozilla had published but not yet shipped to users", at "about $1,000 in compute to successfully attack each Firefox version." (Epoch AI). For anyone running hospital or lab systems, the days between a published fix and an installed one are now the cheap window.

Startups and deals

An AI lab buys a one-person biotech. Anthropic acquired Mithril Medicine, whose founder "used Claude to organize contracts, logistics, and experiments with 11 external labs"; it "took a possible treatment for one form of muscular dystrophy from an idea to promising results in mice in less than 18 months." "All of this research is still at an early stage." (Anthropic). Edison's AI scientist, meanwhile, "will access Pfizer's data to support Pfizer's scientists, inform critical decisions in R&D" (Edison Scientific). A venture investor's caveat: "AI today is predominantly democratizing design around known targets, known drug scaffolds, and known biology." (LifeSciVC). A lean core with contracted wet labs now has a worked example.

Eggs grown outside the body. Ferring is buying Gameto, whose product relies on "stem cell-derived ovarian support cells to grow eggs outside the body" (BioPharma Dive).

Repos and tools

A backdoored coding extension. A security firm found the Claude Code extension on Cursor's marketplace compromised in "Claude Code for VSCode 2.1.312 or 2.1.313"; it "drops a persistent SSH backdoor across macOS, Linux, and Windows", and "uninstalling the extension alone won't remove the backdoor" (Phorion). Anyone with those versions should clean up and rotate credentials.

DeepSeek's always-on repository agent. "dsh-superagent is a proactive coding agent for one GitHub repository", designed to "take as little human attention as possible, and give as much value as possible." MIT-licensed, marked as a research prototype (GitHub).

An open droplet-microfluidics station from Chile. "The strobe-enhanced microscopy stage is a free and open-source workstation for imaging fast processes, particularly developed for microfluidic droplet generation." (Wenzel Lab, GitHub). It runs on a Raspberry Pi and an OpenFlexure base, with open hardware licences.

AI: using it well

The analyst kept the argument and forgot where it came from

"Afterward, when asked to explain their choices, 77% of analysts used the agents' own arguments—sometimes word for word—but only 15% credited the agent as the source of those arguments." — Anthropic

Fifty analysts each ran one causal analysis with a coding agent whose lean on four choices was set by a hidden coin flip. The authors deliberately strengthened the lean and say "We don't know how much this tells us about the real world." A practical consequence: write down the model, covariates and exclusions before reading the agent's case for them.

Novelty judges are only as stable as their prompt

Ai2 found that "seemingly small changes to the evaluation setup produce dramatically different judgments of the same ideas", and released the benchmark so others can test a judge on their own kind of ideas (Ai2). On reviewing, the genomics researcher quoted above makes a personal pledge: "if you see an AI-generated review, it won't come from me." (Heng Li).

Other frontiers

A microscope run by agents, with deterministic code holding the keys. "We introduce an autonomous multi-agent system that turns plain language goals into measurements and statistically tested answers, gating and executing every action in deterministic code." (Nieves Vasquez et al., bioRxiv). The software is not released with the paper.

Colour sensors that keep the light. Instead of filtering, "A color router instead steers those colors towards the corresponding sensing regions, allowing three times more of the incoming light to be used", and printed devices "achieved about 70 percent efficiency" (optics.org). Useful for any low-light colour imaging, fluorescence included.

Refocusing through tissue on a chip. Integrated photonics from imec and KU Leuven "can operate at update rates of around 5,000 wavefront corrections per second, which makes it significantly faster than conventional liquid crystal-based modulators." (Laser Focus World). That is fast enough to chase tissue that moves.

Patents

A Hong Kong applicant was granted a claim that reads cell-free DNA length without sequencing: two probes lighting up in one digital partition show a molecule "that covers the first region and the second region" (USPTO). Boston hospitals hold a broad claim on "clustering the single cells based on the presence of the mutations in mitochondria", inferring clonal lineage with no engineered barcode (USPTO).

Big tech

"Alphabet's stock fell 12.6 percent, erasing around $500 billion in market value", because "increased usage of Google's AI Mode is hurting the company because it makes less money than traditional search" (Platformer). It turns out answering the question pays less than pointing at someone who will.

Corners of the web

A microbiologist on a genomics server: "after sequencing about 40 species with a collaborator, I'm pretty sure dorado's own polisher consistently inserts erroneous bases after certain archaeal methylation sites. --bacteria mode seem to mostly remedy it." (genomic.social). A systematic error from the vendor's own model, visible only once enough species had been sequenced.

People and good examples

Colombia: ex-combatants built three hundred cooperatives where twenty-five were planned

(translated from Spanish) "Ten years after the peace agreement between the national government and the former FARC was signed, in 2026 around 85% of the signatories were still taking part in reintegration programmes, according to UN figures." "To date, more than 300 cooperatives have been founded, although not all of them operate today." — La Silla Vacía Original: "Diez años después de la firma del Acuerdo de Paz entre el gobierno nacional y las antiguas Farc, en 2026 alrededor del 85% de los firmantes seguían participando en programas de reincorporación, según cifras de la ONU." "A la fecha, se han fundado más de 300 cooperativas, aunque no todas funcionan hoy."

The author is candid that "most cannot pay wages or sustain life after the agreement" (original: "la mayoría no puede pagar sueldos ni sostener la vida en el posacuerdo"). Participation held through a collective structure even where the businesses did not.

Leon Esterowitz, founder of a funding line that named a field

"Leon Esterowitz was the founding director of the Biophotonics program at the National Science Foundation (NSF)." "What began as a temporary NSF initiative became a permanent biophotonics program." — Backman et al., Biophotonics Discovery 2026, CC BY 4.0

A laser physicist, he "saw that NSF could play an important role in identifying and nurturing promising ideas at an earlier stage"; the authors trace their own cancer-detection methods to his grants.

Reads and ideas

The payer who could say no. Tony Lo Sasso, a health economist, on US employers: "Employers should be the natural check on this process, but few are engaged health care purchasers." His remedy is to steer people when they choose a plan, because "A hospital can waive copays, but it can't pay your premium." (STAT).

Kill ten ideas before founding one. The UK's ARIA interviews a programme for scientists who have not yet started a company: "we invite scientists and engineers to explore ten potential ideas", and "We encourage them to try to kill ideas rather than confirm them." Also: "scientific evidence alone isn't enough to build a company." (ARIA).

In defence of the dilettante, which this newsletter reads with some personal interest: "The dilettante is a wayfaring cosmopolitan whose sense of freedom is found in never being stuck in one place." (Aeon).

Book of the day

Exit, Voice, and Loyalty — Albert O. Hirschman (1970)

When an organisation declines, its users either leave or complain, and the most demanding leave first. The case that started the book was Nigeria's state railway: "The most demanding customers moved their business, which took away the angry voices that had afflicted the railways", while public funding continued, a pattern Hirschman called a "lazy public monopoly" (Labaree). He later saw the two working together, in East Germany in 1989, when "large-scale flights of citizens to the Federal Republic of Germany combined with increasingly powerful mass demonstrations in the major cities to bring down the communist regime" (World Politics 1993). The strongest critique comes from health care: after England let patients choose hospitals, "mortality fell more quickly (i.e. quality improved) for patients living in more competitive markets" (Cooper et al., LSE). The book is short, and chapters one to five hold the argument.